UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 8, 2014
COLUMBIA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-10352 | 59-2758596 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| 4 Liberty Square Fourth Floor Boston, Massachusetts |
02109 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (617) 639-1500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07. Submission of Matters to a Vote of Security Holders.
At the 2014 Annual Meeting of Stockholders of Columbia Laboratories, Inc. (the “Company”), held on May 8, 2014, three proposals were submitted to and approved by the stockholders. The proposals are described in detail in the Company’s Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on March 31, 2014. The final results for the votes regarding each proposal are set forth below.
1. Stockholders elected seven directors to the Company’s Board of Directors to hold office for a one-year term until the annual meeting of stockholders in 2015 and until their successors are elected and qualified. The votes regarding this proposal were as follows:
| For | Withheld | Abstained | Broker Non-Votes | |||||||||||||
| Valerie L. Andrews |
2,956,867 | 421,625 | 0 | 5,793,542 | ||||||||||||
| Frank Armstrong |
3,109,742 | 268,750 | 0 | 5,793,542 | ||||||||||||
| Frank C. Condella Jr. |
3,042,515 | 335,977 | 0 | 5,793,542 | ||||||||||||
| Cristina Csimma |
3,083,307 | 295,185 | 0 | 5,793,542 | ||||||||||||
| Donald H. Hunter |
3,083,950 | 294,542 | 0 | 5,793,542 | ||||||||||||
| Steven G. Kasnet |
2,467,127 | 911,365 | 0 | 5,793,542 | ||||||||||||
| Nikin Patel |
3,113,311 | 265,181 | 0 | 5,793,542 | ||||||||||||
2. Stockholders ratified the selection of BDO USA, LLP as independent registered public accounting firm for the fiscal year ending December 31, 2014. The votes regarding this proposal were as follows:
| For | Against | Abstained | Broker Non-Votes | |||||||||||
| 8,958,474 | 145,238 | 68,322 | 0 | |||||||||||
3. Stockholders approved in a non-binding advisory vote, the compensation paid to the Company’s named executive officers. The votes regarding this proposal were as follows:
| For | Against | Abstained | Broker Non-Votes | |||||||||||
| 3,092,025 | 247,628 | 38,838 | 5,793,543 | |||||||||||
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| COLUMBIA LABORATORIES, INC. | ||||
| By: | /s/ Jonathan Lloyd Jones | |||
| Name: | Jonathan Lloyd Jones | |||
| Title: | Vice President & Chief Financial | |||
| Officer | ||||
Date: May 8, 2013